Advertisement

Topics

Tessman Technology Limited Company Profile

03:51 EDT 23rd June 2018 | BioPortfolio

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years later became a wholly owned subsidiary of ILEX Oncology Services, located in San Antonio Texas. There was a managerial buy-out of the company in 2001 with retention of all key managerial and clinical operations staff.

Location

5th Floor Standard Life House, 2 West Regent Street,
Glasgow
Scotland
United Kingdom

Contact

Phone: 44 141 331 9310
Fax: 44 141 331 3793
Email: dtessman@tessmantechnology.com


News Articles [73 Associated News Articles listed on BioPortfolio]

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussi...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of...

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today that it has received a milestone payment from the Company’s Chinese partner for efti...

Quotient Limited Reports Commencement of EU Blood Grouping Field Trial

JERSEY, Channel Islands, May 17, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported that it has completed the verification and validatio...

Quotient Limited appoints Franz Walt as Chief Executive Officer

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...

Global MultiWalled Carbon Nanotubes Market Research Report 20112023 [Report Updated: 10012018] Prices from USD $3560

SummaryThe global MultiWalled Carbon Nanotubes market will reach xxx Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define, segment, and project the market on the basis of p...

PubMed Articles [603 Associated PubMed Articles listed on BioPortfolio]

Does technology really enhance nurse education?

Technology has clearly impacted upon our working lives, and the purpose of this paper is to offer a critical insight into the ubiquitous presence of technology in nurse education. This paper argues th...

Everyday technology use among older deaf adults.

Technology holds great potential to support Deaf individuals as they age into older adulthood. However, it is unclear to what extent Deaf seniors are using technology in everyday life or whether they ...

Assistive technology provision: towards an international framework for assuring availability and accessibility of affordable high-quality assistive technology.

This is a position paper describing the elements of an international framework for assistive technology provision that could guide the development of policies, systems and service delivery procedures ...

Content analysis to locate assistive technology in Queensland's motor injury insurance rehabilitation legislation and guidelines.

Reforms to Australia's disability and rehabilitation sectors have espoused the potential of assistive technology as an enabler. As new insurance systems are being developed it is timely to examine the...

Health Information Technology Usability Evaluation Scale (Health-ITUES) for Usability Assessment of Mobile Health Technology: Validation Study.

Mobile technology has become a ubiquitous technology and can be particularly useful in the delivery of health interventions. This technology can allow us to deliver interventions to scale, cover broad...

Clinical Trials [1292 Associated Clinical Trials listed on BioPortfolio]

User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™

The primary aim of this study is to demonstrate the maintenance of healthy peri-stomal skin over a two month period in subjects who use ConvaTec Moldable Technology™ Skin Barriers as par...

Safety and Efficacy of Using GlucoSat Technology For Non-Invasive Glucose Measurement

This study is a prospective, open label, controlled, single center study. 40 patients will be recruited for the study, according to patients’ inflow and meeting eligibility criteria. Pr...

A Pilot Test of t:Slim X2 With Control-IQ Technology

A 36-48 hour admission testing the t:slim X2 with Control-IQ Technology

Endoleak Repair Guided by Navigation Technology

The study is aimed at investigating whether repair of endoleak type II can be improved by adding navigation technology. Can this technology increase precision by guiding the needle that pu...

Improving Outcomes Using Technology for Children Who Are DHH

This study evaluates the efficacy of using augmentative and alternative communication (AAC) technology for enhancing language development in children who are deaf or hard of hearing. Half ...

Companies [523 Associated Companies listed on BioPortfolio]

Tessman Technology Limited

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years l...

Test-Mall

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years l...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Benitec Ltd

Benitec Limited is developing new novel treatments for chronic and life-threatening conditions based on a transformational technology, DNA-directed RNA interference (ddRNAi) - som...

More Information about "Tessman Technology Limited" on BioPortfolio

We have published hundreds of Tessman Technology Limited news stories on BioPortfolio along with dozens of Tessman Technology Limited Clinical Trials and PubMed Articles about Tessman Technology Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tessman Technology Limited Companies in our database. You can also find out about relevant Tessman Technology Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record